Latest Unoprostone Stories
TOKYO, Aug. 25 /PRNewswire/ -- We are pleased to announce that subject enrollment for the phase 2 clinical study of 0.15% UF-021 (generic name; isopropyl unoprostone; active ingredient of Rescula(R) eye-drops) in patients with retinitis pigmentosa has been completed. We submitted the notification of the clinical trial in August 2008. Enrollment in the phase 2 study began at six clinical sites in late December 2008 and was completed on August 3, 2009. The clinical study has progressed with...
- A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
- A ghost, wraith, hobgoblin, elf, or spirit.